Discontinuation report MIDAZOLAM INJECTION

Last updated on 2020-10-19 History
Report ID 126640
Drug Identification Number 02423758
Brand name MIDAZOLAM INJECTION
Common or Proper name MIDAZOLAM INJECTION
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) MIDAZOLAM
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 5mL ampoules
ATC code N05CD
ATC description HYPNOTICS AND SEDATIVES
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-02-01
Remaining supply date 2021-02-01
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-10-19 French Compare
v1 2020-10-19 English Compare